ID   GNAS3_HUMAN             Reviewed;         245 AA.
AC   O95467; B2RB88; E1P5G2; O95417;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   07-APR-2021, entry version 137.
DE   RecName: Full=Neuroendocrine secretory protein 55;
DE            Short=NESP55;
DE   Contains:
DE     RecName: Full=LHAL tetrapeptide;
DE   Contains:
DE     RecName: Full=GPIPIRRH peptide;
DE   Flags: Precursor;
GN   Name=GNAS {ECO:0000312|HGNC:HGNC:4392};
GN   Synonyms=GNAS1 {ECO:0000312|EMBL:CAA08889.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000312|EMBL:CAA08889.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9860993; DOI=10.1073/pnas.95.26.15475;
RA   Hayward B.E., Moran V., Strain L., Bonthron D.T.;
RT   "Bidirectional imprinting of a single gene: human GNAS1 encodes distinct
RT   maternally, paternally and biallelically derived proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15475-15480(1998).
RN   [2] {ECO:0000312|EMBL:CAB83214.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10749992; DOI=10.1093/hmg/9.5.835;
RA   Hayward B.E., Bonthron D.T.;
RT   "An imprinted antisense transcript at the human GNAS1 locus.";
RL   Hum. Mol. Genet. 9:835-841(2000).
RN   [3] {ECO:0000312|EMBL:AAF63226.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10729789; DOI=10.1159/000054535;
RA   Weiss U., Ischia R., Eder S., Lovisetti-Scamihorn P., Bauer R.,
RA   Fischer-Colbrie R.;
RT   "Neuroendocrine secretory protein 55 (NESP55): alternative splicing onto
RT   transcripts of the GNAS gene and posttranslational processing of a
RT   maternally expressed protein.";
RL   Neuroendocrinology 71:177-186(2000).
RN   [4] {ECO:0000312|EMBL:AAD11804.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Wang Y.Z., Kehlenbach R.H., Huttner W.B.;
RT   "Molecular characterization of XL2, a neuroendocrine-specific luminal
RT   Golgi-resident protein.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6] {ECO:0000312|EMBL:AAD11804.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=11067869; DOI=10.1172/jci10431;
RA   Liu J., Litman D., Rosenberg M.J., Yu S., Biesecker L.G., Weinstein L.S.;
RT   "A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.";
RL   J. Clin. Invest. 106:1167-1174(2000).
RN   [8]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=11294659; DOI=10.1086/320117;
RA   Bastepe M., Lane A.H., Jueppner H.;
RT   "Paternal uniparental isodisomy of chromosome 20q -- and the resulting
RT   changes in GNAS1 methylation -- as a plausible cause of
RT   pseudohypoparathyroidism.";
RL   Am. J. Hum. Genet. 68:1283-1289(2001).
RN   [9]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=11029463; DOI=10.1074/jbc.m006032200;
RA   Wu W.-I., Schwindinger W.F., Aparicio L.F., Levine M.A.;
RT   "Selective resistance to parathyroid hormone caused by a novel uncoupling
RT   mutation in the carboxyl terminus of G alpha(s). A cause of
RT   pseudohypoparathyroidism type Ib.";
RL   J. Biol. Chem. 276:165-171(2001).
RN   [10]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=12858292; DOI=10.1086/377136;
RA   Jan de Beur S., Ding C., Germain-Lee E., Cho J., Maret A., Levine M.A.;
RT   "Discordance between genetic and epigenetic defects in
RT   pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal
RT   imprinting at GNAS1.";
RL   Am. J. Hum. Genet. 73:314-322(2003).
RN   [11]
RP   INVOLVEMENT IN AIMAH1.
RX   PubMed=12727968; DOI=10.1210/jc.2002-021362;
RA   Fragoso M.C.B.V., Domenice S., Latronico A.C., Martin R.M., Pereira M.A.A.,
RA   Zerbini M.C.N., Lucon A.M., Mendonca B.B.;
RT   "Cushing's syndrome secondary to adrenocorticotropin-independent
RT   macronodular adrenocortical hyperplasia due to activating mutations of
RT   GNAS1 gene.";
RL   J. Clin. Endocrinol. Metab. 88:2147-2151(2003).
RN   [12]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=14561710; DOI=10.1172/jci200319159;
RA   Bastepe M., Froehlich L.F., Hendy G.N., Indridason O.S., Josse R.G.,
RA   Koshiyama H., Koerkkoe J., Nakamoto J.M., Rosenbloom A.L., Slyper A.H.,
RA   Sugimoto T., Tsatsoulis A., Crawford J.D., Jueppner H.;
RT   "Autosomal dominant pseudohypoparathyroidism type Ib is associated with a
RT   heterozygous microdeletion that likely disrupts a putative imprinting
RT   control element of GNAS.";
RL   J. Clin. Invest. 112:1255-1263(2003).
RN   [13]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=15800843; DOI=10.1086/429932;
RA   Linglart A., Gensure R.C., Olney R.C., Jueppner H., Bastepe M.;
RT   "A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type
RT   Ib redefines the boundaries of a cis-acting imprinting control element of
RT   GNAS.";
RL   Am. J. Hum. Genet. 76:804-814(2005).
RN   [14]
RP   INVOLVEMENT IN PHP1B.
RX   PubMed=15592469; DOI=10.1038/ng1487;
RA   Bastepe M., Froehlich L.F., Linglart A., Abu-Zahra H.S., Tojo K.,
RA   Ward L.M., Jueppner H.;
RT   "Deletion of the NESP55 differentially methylated region causes loss of
RT   maternal GNAS imprints and pseudohypoparathyroidism type Ib.";
RL   Nat. Genet. 37:25-27(2005).
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle
CC       {ECO:0000250}. Secreted {ECO:0000250}. Note=Neuroendocrine secretory
CC       granules. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=Nesp55 {ECO:0000269|PubMed:10729789, ECO:0000269|PubMed:10749992,
CC       ECO:0000269|PubMed:9860993, ECO:0000269|Ref.4};
CC         IsoId=O95467-1; Sequence=Displayed;
CC       Name=XLas-1;
CC         IsoId=Q5JWF2-1; Sequence=External;
CC       Name=XLas-2;
CC         IsoId=Q5JWF2-2; Sequence=External;
CC       Name=XLas-3;
CC         IsoId=Q5JWF2-3; Sequence=External;
CC       Name=Gnas-1 {ECO:0000305}; Synonyms=Alpha-S2 {ECO:0000305}, GNASl
CC       {ECO:0000305}, Alpha-S-long {ECO:0000305};
CC         IsoId=P63092-1, P04895-1;
CC         Sequence=External;
CC       Name=Gnas-2 {ECO:0000305}; Synonyms=Alpha-S1 {ECO:0000305}, GNASs
CC       {ECO:0000305}, Alpha-S-short {ECO:0000305};
CC         IsoId=P63092-2, P04895-2;
CC         Sequence=External;
CC       Name=3;
CC         IsoId=P63092-3; Sequence=External;
CC       Name=4;
CC         IsoId=P63092-4; Sequence=External;
CC   -!- PTM: Binds keratan sulfate chains. {ECO:0000250|UniProtKB:O18979}.
CC   -!- PTM: May be proteolytically processed to give rise to a number of
CC       active peptides. {ECO:0000269|PubMed:10729789}.
CC   -!- DISEASE: ACTH-independent macronodular adrenal hyperplasia 1 (AIMAH1)
CC       [MIM:219080]: A rare adrenal defect characterized by multiple,
CC       bilateral, non-pigmented, benign, adrenocortical nodules. It results in
CC       excessive production of cortisol leading to ACTH-independent Cushing
CC       syndrome. Clinical manifestations of Cushing syndrome include facial
CC       and truncal obesity, abdominal striae, muscular weakness, osteoporosis,
CC       arterial hypertension, diabetes. {ECO:0000269|PubMed:12727968}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Pseudohypoparathyroidism 1B (PHP1B) [MIM:603233]: A disorder
CC       characterized by end-organ resistance to parathyroid hormone,
CC       hypocalcemia and hyperphosphatemia. Patients affected with PHP1B lack
CC       developmental defects characteristic of Albright hereditary
CC       osteodystrophy, and typically show no other endocrine abnormalities
CC       besides resistance to PTH. {ECO:0000269|PubMed:11029463,
CC       ECO:0000269|PubMed:11067869, ECO:0000269|PubMed:11294659,
CC       ECO:0000269|PubMed:12858292, ECO:0000269|PubMed:14561710,
CC       ECO:0000269|PubMed:15592469, ECO:0000269|PubMed:15800843}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. Most affected individuals have defects in methylation of the
CC       gene. In some cases microdeletions involving the STX16 appear to cause
CC       loss of methylation at exon A/B of GNAS, resulting in PHP1B. Paternal
CC       uniparental isodisomy have also been observed.
CC   -!- DISEASE: GNAS hyperfunction (GNASHYP) [MIM:139320]: This condition is
CC       characterized by increased trauma-related bleeding tendency, prolonged
CC       bleeding time, brachydactyly and mental retardation. Both the XLas
CC       isoforms and the ALEX protein are mutated which strongly reduces the
CC       interaction between them and this may allow unimpeded activation of the
CC       XLas isoforms. Note=The disease is caused by variants affecting the
CC       gene represented in this entry.
CC   -!- MISCELLANEOUS: This protein is produced by a bicistronic gene which
CC       also produces the ALEX protein from an overlapping reading frame.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: The GNAS locus is imprinted in a complex manner, giving
CC       rise to distinct paternally, maternally and biallelically expressed
CC       proteins. The XLas isoforms are paternally derived, the Gnas isoforms
CC       are biallelically derived and the Nesp55 isoforms are maternally
CC       derived.
CC   -!- MISCELLANEOUS: [Isoform Nesp55]: Shares no sequence similarity with
CC       other isoforms due to a novel first exon containing the entire reading
CC       frame spliced to shared exon 2 so that exons 2-13 make up the 3'-UTR.
CC   -!- SIMILARITY: Belongs to the NESP55 family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ009849; CAA08889.1; -; Genomic_DNA.
DR   EMBL; AJ251760; CAB83214.1; -; Genomic_DNA.
DR   EMBL; AF105253; AAF63226.1; -; mRNA.
DR   EMBL; AF107846; AAD11804.1; -; Genomic_DNA.
DR   EMBL; AK314549; BAG37135.1; -; mRNA.
DR   EMBL; CH471077; EAW75466.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75457.1; -; Genomic_DNA.
DR   CCDS; CCDS13471.1; -. [O95467-1]
DR   RefSeq; NP_000507.1; NM_000516.5.
DR   RefSeq; NP_001070956.1; NM_001077488.3.
DR   RefSeq; NP_001070957.1; NM_001077489.3.
DR   RefSeq; NP_001296790.1; NM_001309861.1.
DR   RefSeq; NP_057676.1; NM_016592.3. [O95467-1]
DR   RefSeq; NP_536351.1; NM_080426.3.
DR   RefSeq; XP_016883310.1; XM_017027821.1. [O95467-1]
DR   RefSeq; XP_016883311.1; XM_017027822.1. [O95467-1]
DR   SMR; O95467; -.
DR   BioGRID; 109040; 147.
DR   iPTMnet; O95467; -.
DR   BioMuta; GNAS; -.
DR   MassIVE; O95467; -.
DR   PeptideAtlas; O95467; -.
DR   PRIDE; O95467; -.
DR   ProteomicsDB; 50901; -. [O95467-1]
DR   Antibodypedia; 4152; 770 antibodies.
DR   DNASU; 2778; -.
DR   Ensembl; ENST00000313949; ENSP00000323571; ENSG00000087460. [O95467-1]
DR   Ensembl; ENST00000371075; ENSP00000360115; ENSG00000087460. [O95467-1]
DR   Ensembl; ENST00000371098; ENSP00000360139; ENSG00000087460. [O95467-1]
DR   Ensembl; ENST00000419558; ENSP00000416234; ENSG00000087460. [O95467-1]
DR   Ensembl; ENST00000453292; ENSP00000392000; ENSG00000087460. [O95467-1]
DR   GeneID; 2778; -.
DR   KEGG; hsa:2778; -.
DR   UCSC; uc002xzt.5; human. [O95467-1]
DR   CTD; 2778; -.
DR   DisGeNET; 2778; -.
DR   GeneCards; GNAS; -.
DR   GeneReviews; GNAS; -.
DR   HGNC; HGNC:4392; GNAS.
DR   HPA; ENSG00000087460; Tissue enhanced (pituitary gland, thyroid gland).
DR   MalaCards; GNAS; -.
DR   MIM; 139320; gene+phenotype.
DR   MIM; 219080; phenotype.
DR   MIM; 603233; phenotype.
DR   neXtProt; NX_O95467; -.
DR   OpenTargets; ENSG00000087460; -.
DR   PharmGKB; PA175; -.
DR   VEuPathDB; HostDB:ENSG00000087460.23; -.
DR   GeneTree; ENSGT00940000156300; -.
DR   HOGENOM; CLU_100255_0_0_1; -.
DR   OrthoDB; 754573at2759; -.
DR   PathwayCommons; O95467; -.
DR   BioGRID-ORCS; 2778; 21 hits in 1007 CRISPR screens.
DR   ChiTaRS; GNAS; human.
DR   GeneWiki; GNAS_complex_locus; -.
DR   GenomeRNAi; 2778; -.
DR   Pharos; O95467; Tbio.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000087460; Expressed in type B pancreatic cell and 264 other tissues.
DR   ExpressionAtlas; O95467; baseline and differential.
DR   Genevisible; O95467; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030133; C:transport vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0007565; P:female pregnancy; NAS:UniProtKB.
DR   GO; GO:0040015; P:negative regulation of multicellular organism growth; ISS:UniProtKB.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0009306; P:protein secretion; NAS:UniProtKB.
DR   GO; GO:0071107; P:response to parathyroid hormone; IMP:UniProtKB.
DR   InterPro; IPR009434; NESP55.
DR   Pfam; PF06390; NESP55; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cleavage on pair of basic residues; Cushing syndrome;
KW   Cytoplasmic vesicle; Glycoprotein; Proteoglycan; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..46
FT                   /evidence="ECO:0000250"
FT   CHAIN           47..245
FT                   /note="Neuroendocrine secretory protein 55"
FT                   /id="PRO_0000253967"
FT   PEPTIDE         163..166
FT                   /note="LHAL tetrapeptide"
FT                   /evidence="ECO:0000255, ECO:0000303|PubMed:10729789"
FT                   /id="PRO_0000253968"
FT   PEPTIDE         238..245
FT                   /note="GPIPIRRH peptide"
FT                   /evidence="ECO:0000255, ECO:0000303|PubMed:10729789"
FT                   /id="PRO_0000253969"
FT   COMPBIAS        78..142
FT                   /note="Glu-rich"
FT                   /evidence="ECO:0000255"
FT   CONFLICT        26
FT                   /note="R -> C (in Ref. 4; AAD11804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        41
FT                   /note="L -> D (in Ref. 4; AAD11804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        72
FT                   /note="G -> GR (in Ref. 4; AAD11804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        133
FT                   /note="P -> PETAP (in Ref. 4)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        171
FT                   /note="P -> A (in Ref. 4; AAD11804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211..219
FT                   /note="KEEKQRRRC -> REENSSDSS (in Ref. 4; AAD11804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        230
FT                   /note="S -> F (in Ref. 4; AAD11804)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   245 AA;  28029 MW;  4F02B8B1115089E2 CRC64;
     MDRRSRAQQW RRARHNYNDL CPPIGRRAAT ALLWLSCSIA LLRALATSNA RAQQRAAAQQ
     RRSFLNAHHR SGAQVFPESP ESESDHEHEE ADLELSLPEC LEYEEEFDYE TESETESEIE
     SETDFETEPE TAPTTEPETE PEDDRGPVVP KHSTFGQSLT QRLHALKLRS PDASPSRAPP
     STQEPQSPRE GEELKPEDKD PRDPEESKEP KEEKQRRRCK PKKPTRRDAS PESPSKKGPI
     PIRRH
//
